UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040967
Receipt number R000046786
Scientific Title Effectiveness of combined use of theanine and arginine for psychological stress
Date of disclosure of the study information 2020/07/01
Last modified on 2021/11/15 15:51:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of combined use of theanine and arginine for psychological stress

Acronym

Effectiveness of combined use of theanine and arginine for psychological stress

Scientific Title

Effectiveness of combined use of theanine and arginine for psychological stress

Scientific Title:Acronym

Effectiveness of combined use of theanine and arginine for psychological stress

Region

Japan


Condition

Condition

Healthy person

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examination of the effectiveness of combined use of theanine and arginine for psychological stress

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

salivary alpha-amylase activity

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Theanine drink

Interventions/Control_2

Theanine-arginine drink

Interventions/Control_3

placebo

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Being able to take barley tea
Capable of collecting saliva

Key exclusion criteria

Those taking antihypertensive drugs, stimulants, anxiolytics

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Furushima

Organization

University of Shizuoka

Division name

School of Pharmaceutical Science

Zip code

422-8526

Address

52-1 Yada Surugaku Shizuoka

TEL

054-264-5591

Email

dfuru@u-shizuoka-ken.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Furushima

Organization

University of Shizuoka

Division name

School of Pharmaceutical Science

Zip code

422-8526

Address

52-1 Yada Surugaku Shizuoka

TEL

054-264-5591

Homepage URL


Email

dfuru@u-shizuoka-ken.ac.jp


Sponsor or person

Institute

University of Shizuoka

Institute

Department

Personal name



Funding Source

Organization

University of Shizuoka

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics committee at University of Shizuoka

Address

52-1 Yada Surugaku Shizuoka

Tel

054-264-5102

Email

dfuru@u-shizuoka-ken.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 12 Month 03 Day

Date of IRB

2018 Year 12 Month 03 Day

Anticipated trial start date

2020 Year 01 Month 01 Day

Last follow-up date

2022 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 07 Month 01 Day

Last modified on

2021 Year 11 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046786


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name